<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Kolohopo - Latest News</title>
<link href="https://news.arcnewswire.com/rss/kolohopo/latest.xml"></link>
<updated>2026-09-20T06:41:21+00:00</updated>
<id>urn:uuid:023276d7-42c9-c6a4-db56-7636fb53924c</id>
<entry>
<title>https://www.facebook.com/GLP.Formula.France.EUR/</title>
<link href="https://news.arcnewswire.com/@kolohopo/https-wwwfacebookcom-glpformulafranceeur-9hl78rf4il4p"></link>
<id>urn:uuid:5a8893bd-3b2a-5e5f-2110-a370b2beea83</id>
<summary type="html"><![CDATA[rapid, aggressive results of pharmaceutical GLP-1 agonists, making it better suited for long-term health rather than quick fixes.]]></summary>
<updated>2025-09-03T06:57:43+00:00</updated>
</entry>
</feed>